Invention Grant
- Patent Title: Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer
-
Application No.: US14762259Application Date: 2014-01-21
-
Publication No.: US09862692B2Publication Date: 2018-01-09
- Inventor: Viranga Tillekeratne , William Taylor , Sara Fedorka
- Applicant: The University of Toledo
- Applicant Address: US OH Toledo
- Assignee: The University of Toledo
- Current Assignee: The University of Toledo
- Current Assignee Address: US OH Toledo
- Agency: MacMillan, Sobanski & Todd, LLC
- International Application: PCT/US2014/012359 WO 20140121
- International Announcement: WO2014/116594 WO 20140731
- Main IPC: C07D277/24
- IPC: C07D277/24 ; C07D277/22

Abstract:
Described herein are analogs of 2-methyl-3-(2-ethynylthiazol-4-yl)cyclopent-2-enol and the corresponding ketone 3-(2-ethynylthiazol-4-yl)-2-methylcyclopent-2-enone, the analogs having terminal alkyne groups at the 2-position of the thiazole ring. These drug-like molecules, referred to as CETZOLE compounds, are useful to treat non-small cell lung cancer and other forms of cancer. Methods of making and using the compounds, methods of treating various diseases, pharmaceutical compositions, and kits are also disclosed.
Public/Granted literature
- US20150344448A1 Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer Public/Granted day:2015-12-03
Information query